Carmignac Gestion’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Carmignac Gestion's BMY Position: Q2 2026 in Review
Carmignac Gestion opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 9,014 shares worth $519K. The stake represents 0.01% of the portfolio and ranks #89 among its holdings. This is a return to the name: Carmignac Gestion previously reported a position in BMY as recently as Q1 2024.
Carmignac Gestion first reported a position in BMY in Q4 2018 and has held it in 3 quarters since. The position peaked at $52.7M in Q4 2018. 2,514 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Carmignac Gestion held 9,014 shares of Bristol-Myers Squibb worth $519K as of Q2 2026.
- Bristol-Myers Squibb was a new Carmignac Gestion position in Q2 2026.
- Bristol-Myers Squibb made up 0.01% of Carmignac Gestion's portfolio in Q2 2026, its #89 holding.
- Carmignac Gestion first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 3 quarters since.
- Carmignac Gestion's Bristol-Myers Squibb position peaked at $52.7M in Q4 2018.
- 2,514 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Carmignac Gestion's 13F filing for Q2 2026, filed 13 Aug 2026.